Heart failure therapy device and method
OwnerJohn M. Adams, Clifton A. Alfernessinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerJohn M. Adams, Clifton A. Alfernessinventors
Estimating the term…
The heart rate of a patient with conditions such as chronic heart failure, ischemia, or acute myocardial infarction is reduced by electrically stimulating the right vagus nerve of the patient. A lead is implanted with electrodes in electrical communication with tissue proximate to the vagus nerve. A stimulator in electrical communication with the electrodes delivers electrical energy that stimulates the release of acetylcholine from the vagus nerve. The amount of energy may be determined in accordance with a difference between the patient's actual heart rate and a maximum target heart rate for the patient. Delivery of energy to the lead electrodes is preferably synchronized with the detection of a P-wave. Automatic adjustment of the target heart rate may be based on current day and/or time of day information, and patient physical activity. The voltage, pulse width, or number of pulses in the stimulation may be controlled.
A device for reducing the normal sinus heart rate of a patient, comprising:
A device for treating heart failure or ischemia in a patient, comprising:
A vagal nerve stimulator, comprising:
A method for reducing the normal sinus heart rate of a patient, comprising:
A method for treating heart failure or ischemia, comprising:
A device for treating cardiovascular disease in a patient, comprising:
A method of treating cardiovascular disease in a patient, comprising:
An electrical lead configured for implantation in a patient's heart, comprising:
Dependencies are inferred from the claim text.